Proteomic biomarkers for acute interstitial lung disease in gefitinib-treated Japanese lung cancer patients

Interstitial lung disease (ILD) events have been reported in Japanese non-small-cell lung cancer (NSCLC) patients receiving EGFR tyrosine kinase inhibitors. We investigated proteomic biomarkers for mechanistic insights and improved prediction of ILD. Blood plasma was collected from 43 gefitinib-trea...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2011-07, Vol.6 (7), p.e22062-e22062
Hauptverfasser: Nyberg, Fredrik, Ogiwara, Atsushi, Harbron, Chris G, Kawakami, Takao, Nagasaka, Keiko, Takami, Sachiko, Wada, Kazuya, Tu, Hsiao-Kun, Otsuji, Makiko, Kyono, Yutaka, Dobashi, Tae, Komatsu, Yasuhiko, Kihara, Makoto, Akimoto, Shingo, Peers, Ian S, South, Marie C, Higenbottam, Tim, Fukuoka, Masahiro, Nakata, Koichiro, Ohe, Yuichiro, Kudoh, Shoji, Clausen, Ib Groth, Nishimura, Toshihide, Marko-Varga, György, Kato, Harubumi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!